Related Experiment Video
Updated: Jun 30, 2025

05:25
Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
Published on: July 21, 2023
1.4K
Pten knockout in mouse preosteoblasts leads to changes in bone turnover and strength
Judith Lorenz1, Sandy Richter1, Anna S Kirstein1,2
1Pediatric Research Center, Leipzig University, University Hospital for Children and Adolescents, Department for Child and Adolescent Medicine, 04103 Leipzig, Germany.
JBMR Plus
|March 20, 2024
Summary
Deleting phosphatase and tensin homolog (Pten) in osteoprogenitor cells enhances bone strength and elasticity. This Pten knockout increases bone mass, osteoblast numbers, and bone marrow stromal cell proliferation and differentiation.
Area of Science:
- Cell Biology
- Biochemistry
- Orthopedics
Background:
- Bone remodeling is regulated by the phosphoinositide-3-kinase (Pi3k) signaling pathway.
- Phosphatase and tensin homolog (Pten) is a negative regulator of Pi3k signaling.
- Dysregulation of Pten is linked to bone disorders.
Purpose of the Study:
- To investigate the effects of Pten downregulation in osteoprogenitors on bone turnover.
- To identify mechanisms regulating bone turnover and bone disorders.
Main Methods:
- Conditional deletion of Pten in Osterix/Sp7-expressing osteoprogenitor cells in mice.
- Bone phenotyping using micro-CT, histomorphometry, and biomechanical testing.
- Analysis of bone marrow stromal cell (BMSC) proliferation and osteogenic differentiation in vitro.
Main Results:
- Pten knockout in osteoprogenitors led to increased trabecular bone volume and altered cortical morphology.
- Increased osteoblast numbers and bone formation rates were observed.
- Pten-deficient BMSCs exhibited enhanced proliferation and osteogenic differentiation capacity.
- Biomechanical analysis showed significantly higher bone strength and elasticity.
Conclusions:
- Pten deficiency in osteoprogenitors enhances bone stability and elasticity.
- Increased trabecular bone mass and improved BMSC function contribute to enhanced bone quality.
- This study highlights the role of the Pten/Pi3k pathway in regulating bone mass and quality.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K

